Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
HRS2398
/
Jiangsu Hengrui Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
HRS2398
/
Jiangsu Hengrui Pharma
Enrollment open, Metastases:
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
(clinicaltrials.gov) - Jan 3, 2022
P1
, N=116, Recruiting,
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Not yet recruiting --> Recruiting
|||
|||||||
HRS2398
/
Jiangsu Hengrui Pharma
New P1 trial, Metastases:
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
(clinicaltrials.gov) - Dec 3, 2021
P1
, N=116, Not yet recruiting,
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.